scholarly journals Advancing Sensor Technology for Aerospace Propulsion

Author(s):  
Fernando Figueroa ◽  
Carolyn R. Mercer

NASA’s Stennis Space Center (SSC) and Glenn Research Center (GRC) participate in the development of technologies for propulsion testing and propulsion applications in air and space transportation. Future transportation systems and the test facilities needed to develop and sustain them are becoming increasingly complex. Sensor technology is a fundamental pillar that makes possible development of complex systems that must operate in automatic mode (closed loop systems), or even in assisted-autonomous mode (highly self-sufficient systems such as planetary exploration spacecraft). Hence, a great deal of effort is dedicated to develop new sensors and related technologies to be used in research facilities, test facilities, and in vehicles and equipment. This paper describes sensor technologies being developed and in use at SSC and GRC, including new technologies in integrated health management involving sensors, components, processes, and vehicles.

2011 ◽  
Vol 2011 ◽  
pp. 1-14 ◽  
Author(s):  
K. Selvarajah ◽  
C. Shooter ◽  
L. Liotti ◽  
A. Tully

The important innovations in wireless and digital electronics will support many applications in the areas of safety, environmental and emissions control, driving assistance, diagnostics, and maintenance in the transport domain. The last few years have seen the emergence of many new technologies that can potentially have major impacts on transportation systems. One of these technologies is Wireless Sensor Networks. A wireless sensor device is typically composed of a processing unit, memory, and a radio chip which allows it to communicate wirelessly with other devices within range. The Embedded Middleware in Mobility Applications (EMMA) project delivers a middleware that aims to facilitate the interaction between sensing technologies in transportation systems. This paper outlines our experience in the EMMA project and provides an illustration of the important role that wireless sensor technology can play in future transportation system. The paper discusses our experience of using heterogeneous sensors to develop transportation system applications in the EMMA project and focuses on how cooperation between vehicle and infrastructure can be addressed. It also presents encouraging results obtained from the experiments in investigating the feasibility of utilising wireless sensor in vehicle and vehicle-to-infrastructure communication in real transportation applications.


2021 ◽  
pp. 193229682110413
Author(s):  
Bernhard Kulzer ◽  
Lutz Heinemann ◽  
Timm Roos

Background: Little is little known about how people with diabetes experience advancing digitization and new technologies in diabetes. Research question: What are the attitudes of people with diabetes (or, in the case of children with diabetes, their parents) toward digitization and advancing technology in diabetology? What significant advantages and disadvantages do they see, and how do they assess current developments of digitization in diabetology (eg, hybrid closed-loop systems, do-It-Yourself (DIY) closed-loop systems, data protection, and data donation)? Material and method: 3,427 people with diabetes (47.7% female, 65.6% type 1 diabetes (T1D), 25.5% type 2 diabetes (T2D), 8.1% parents of children with diabetes; 0.8% other type of diabetes, age 49.2 ± 19.3 years) were interviewed with an online survey. Results: Overall, survey participants had a very positive attitude toward digitization (82.6%) and considered the potential for optimizing diabetology through digitization to be very high (78.8%). The highest rated advantages of digitization were “greater personal responsibility and self-determination in therapy” (80.0%), “better quality of treatment” (80.0%), and “better communication with the doctor/diabetes team” (77.3%), while the highest rated disadvantages were the “error-proneness of digital applications” (35.9%), the “risk of misuse of patient data” (32.3%) and the “fear that digitization will replace the doctor in many cases” (31.1%). The possibility of evaluating and analyzing glucose data by means of software, and AID systems, and the possibility of improving the interoperability of the various applications are currently rated as the most significant topics. Conclusions: The vast majority of people with diabetes are very positive about new technologies in diabetology and expect that it will improve and simplify their diabetes therapy and reduce the burdens associated with diabetes. In particular, people with type 1 diabetes have high expectations for AID systems, viewing them as a kind of “technical cure” for their diabetes.


2016 ◽  
Vol 2016 (4) ◽  
pp. 8-10 ◽  
Author(s):  
B.I. Kuznetsov ◽  
◽  
A.N. Turenko ◽  
T.B. Nikitina ◽  
A.V. Voloshko ◽  
...  

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 102-LB
Author(s):  
MARC D. BRETON ◽  
ROY BECK ◽  
RICHARD M. BERGENSTAL ◽  
BORIS KOVATCHEV

2020 ◽  
Author(s):  
Anthony Pease ◽  
Clement Lo ◽  
Arul Earnest ◽  
Velislava Kiriakova ◽  
Danny Liew ◽  
...  

<b>Background: </b>Time-in-range is a key glycaemic metric, and comparisons of management technologies for this outcome are critical to guide device selection. <p><b> </b></p> <p><b>Purpose: </b>We conducted a systematic review and network meta-analysis to compare and rank technologies for time in glycaemic ranges.</p> <p> </p> <p><b>Data sources: </b>We searched All Evidenced Based Medicine Reviews, CINAHL, EMBASE, MEDLINE, MEDLINE In-Process and other non-indexed citations, PROSPERO, PsycINFO, PubMed, and Web of Science until 24 April, 2019.</p> <p> </p> <p><b>Study selection: </b>We included randomised controlled trials <u>></u>2 weeks duration comparing technologies for management of type 1 diabetes in adults (<u>></u>18 years of age), excluding pregnant women. </p> <p> </p> <p><b>Data extraction: </b>Data were extracted using a predefined template. Outcomes were percent time with sensor glucose levels 3.9–10.0mmol/l (70–180mg/dL), >10.0mmol/L (180mg/dL), and <3.9mmol/L (70mg/dL). </p> <p><b> </b></p> <p><b>Data synthesis: </b>We identified 16,772 publications, of which 14 eligible studies compared eight technologies comprising 1,043 participants. Closed loop systems lead to greater percent time-in-range than any other management strategy and was 17.85 (95% predictive interval [PrI] 7.56–28.14) higher than usual care of multiple daily injections with capillary glucose testing. Closed loop systems ranked best for percent time-in-range or above range utilising surface under the cumulative ranking curve (SUCRA–98.5 and 93.5 respectively). Closed loop systems also ranked highly for time below range (SUCRA–62.2). </p> <p><b> </b></p> <p><b>Limitations: </b>Overall risk of bias ratings were moderate for all outcomes. Certainty of evidence was very low.</p> <p><b> </b></p> <p><b>Conclusions: </b>In the first integrated comparison of multiple management strategies considering time-in-range, we found that the efficacy of closed loop systems appeared better than all other approaches. </p>


Sign in / Sign up

Export Citation Format

Share Document